Instrument Inactif

Communiqués Quest PharmaTech Inc Toronto S.E.

Actions

QPT

CA74836M1068

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director	30/05	AQ
Quest Receives Cash Dividend Payment from OncoQuest	30/01	AQ
Quest PharmaTech Inc. - Oregovomab Phase III Clinical Study fails futility analysis, Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	24/01	AQ
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	23/01	AQ
Quest PharmaTech Provides Corporate Update	13/09/23	AQ
Quest PharmaTech Announces Results from AGM	14/07/23	AQ
Quest PharmaTech Provides Product Development Update	10/07/23	AQ
Quest PharmaTech Provides Corporate Update	09/06/23	AQ
Canadian Investment Regulatory Organization Trade Resumption - QPT	07/06/23	AQ
Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.	06/06/23	AQ
Canadian Investment Regulatory Organization Trading Halt - QPT	06/06/23	AQ
Quest PharmaTech Provides Corporate Update	02/06/23	AQ
Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology License	28/09/22	AQ
Quest PharmaTech Announces Results from AGM	21/07/22	AQ
Quest PharmaTech Provides Corporate Update	19/04/22	AQ
Quest PharmaTech : September 1, 2021 OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian Cancer	02/09/21	PU
Quest PharmaTech : OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian Cancer	01/09/21	AQ
Quest PharmaTech : July 7, 2021 Quest PharmaTech Announces Results from AGM	08/07/21	PU
Quest PharmaTech : Announces Results from AGM	07/07/21	AQ
Quest PharmaTech : June 1, 2021 Quest PharmaTech Announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American Association of Clinical Oncologists	02/06/21	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Quest PharmaTech Inc Toronto S.E.

Actions

QPT

CA74836M1068

Communiqués

Filtres